Researchers have learned how to stimulate the immune system in animal models to produce large quantities of broadly neutralizing antibodies against HIV—a prerequisite for an effective vaccine.
Children born during the pandemic, including those exposed to COVID-19 in utero, were no more likely to screen positive for autism than unexposed or pre-pandemic children.
The 2024 Lasker-Bloomberg Public Service Award recognizes Quarraisha Abdool Karim and Salim S. Abdool Karim for global contributions to the fight against HIV/AIDS.
On March 22, a donation of N-95 masks arrived at Columbia University Irving Medical Center (CUIMC) donated by Tesla, the American electric vehicle and clean energy company.
The explosion of COVID-19 cases in China was largely driven by people with mild or no symptoms who went undetected, according to a new study from Columbia University Mailman School of Public Health.
The National Institutes of Health has provided the Center for Infection and Immunity live SARS-CoV-2 samples to use in research to develop rapid tests and identify sources of transmission.
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus.
Researchers hoped treatment of HIV-infected infants within hours of birth would increase remission, but a new study finds that starting treatment within the first two weeks leads to similar outcomes.
Op-ed for CNN by Dr. Edith Bracho-Sanchez, a primary care pediatrician and Assistant Professor of Pediatrics at Columbia University Irving Medical Center.
Columbia's David Ho and Wafaa El-Sadr—who have been fighting HIV and AIDS since the beginning of the epidemic in the 1980s—say ending AIDs in the United States by 2030 will take political will.
The first-ever detailed images of a malaria protein, a key modulator of drug resistance, show how the parasite evades antimalarials—and may help scientists find ways to restore the drugs’ potency.